Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT

Witold Cholewinski, Ivan Castellon, Barbara Raphael, Sherif I. Heiba

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

A 37-year-old man with multiple myeloma in remission underwent routine fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) study for disease restaging. Both FDG-PET and CT images showed focal abnormalities in the region of the T6 vertebra, but the fused images that are routinely provided with PET/CT could precisely localize the FDG active lesion to a soft tissue focus in the epidural space, away from a lytic nonactive vertebral body lesion despite their close proximity. The PET/CT scan identified a few other metabolically active osseous lesions out of many lytic bony changes throughout the skeleton. Accordingly, the patient received the correct management for an impending spinal cord compression at the appropriate time, in addition to systemic therapy for disease relapse.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalClinical nuclear medicine
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2009

Keywords

  • F-18 FDG
  • Multiple myeloma
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT'. Together they form a unique fingerprint.

  • Cite this